{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:22:30Z","timestamp":1789564950745,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ejphar.2010.03.018","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T04:21:03Z","timestamp":1269231663000},"page":"49-55","source":"Crossref","is-referenced-by-count":32,"title":["The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family"],"prefix":"10.1016","volume":"635","author":[{"given":"Hiromichi","family":"Kosaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Yoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kitayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.03.018_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejphar.2008.02.001","article-title":"Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R","volume":"584","author":"Akizuki","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.03.018_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2010.03.018_bib3","doi-asserted-by":"crossref","first-page":"31283","DOI":"10.1074\/jbc.M504098200","article-title":"A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor","volume":"280","author":"Bledsoe","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.03.018_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/HYPERTENSIONAHA.107.103580","article-title":"A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity","volume":"51","author":"Dietz","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2010.03.018_bib5","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1093\/emboj\/17.12.3317","article-title":"Antagonism in the human mineralocorticoid receptor","volume":"17","author":"Fagart","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2010.03.018_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0022-3565(24)35127-4","article-title":"Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes","volume":"291","author":"Furukawa","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.03.018_bib7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.bjp.0705944","article-title":"Identification of R(\u2212)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels","volume":"143","author":"Furukawa","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.03.018_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.fjc.0000154374.88283.15","article-title":"Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes","volume":"45","author":"Furukawa","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.03.018_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1126\/science.289.5476.119","article-title":"Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy","volume":"289","author":"Geller","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2010.03.018_bib10","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/nrd1551","article-title":"Principles for modulation of the nuclear receptor superfamily","volume":"3","author":"Gronemeyer","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2010.03.018_bib11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072054","article-title":"Role of actions of calcium antagonists on efferent arterioles\u2014with special references to glomerular hypertension","volume":"23","author":"Hayashi","year":"2003","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejphar.2010.03.018_bib12","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1046\/j.1523-1755.2000.00958.x","article-title":"Mechanistic aspects of mineralocorticoid receptor activation","volume":"57","author":"Hellal-Levy","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2010.03.018_bib13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/me.2004-0537","article-title":"The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms","volume":"19","author":"Hultman","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2010.03.018_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/01.fjc.0000197539.12685.f5","article-title":"Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells","volume":"47","author":"Imagawa","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.03.018_bib15","first-page":"1681","article-title":"Slow dissociation of the new slow-onset and long-acting calcium antagonist benidipine hydrochloride from 3H-nitrendipine binding sites","volume":"38","author":"Ishii","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2010.03.018_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00005344-199710000-00005","article-title":"Diversity in the renal hemodynamic effects of dihydropyridine calcium blockers in spontaneously hypertensive rats","volume":"30","author":"Kawata","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.03.018_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.1999.tb00001.x","article-title":"Benidipine: a new Ca2+ channel blocker with a cardioprotective effect","volume":"17","author":"Kitakaze","year":"1999","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.ejphar.2010.03.018_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molcel.2005.06.026","article-title":"Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor","volume":"19","author":"Li","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2010.03.018_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2010.03.018_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejphar.2010.03.018_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1248\/yakushi1947.115.3_213","article-title":"Studies of novel 1, 4-dihydropyridine Ca antagonist CS-905. I. Measurement of partition coefficient (log P) by high performance liquid chromatography (HPLC)","volume":"115","author":"Masumoto","year":"1995","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ejphar.2010.03.018_bib22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0955-0674(98)80015-X","article-title":"The nuclear receptor ligand-binding domain: structure and function","volume":"10","author":"Moras","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejphar.2010.03.018_bib23","first-page":"1662","article-title":"Synthesis and pharmacological activity of stereoisomers of 1, 4-dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3, 5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester","volume":"38","author":"Muto","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2010.03.018_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2010.03.018_bib25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2010.03.018_bib26","doi-asserted-by":"crossref","first-page":"22782","DOI":"10.1016\/S0021-9258(18)41595-5","article-title":"Expression cloning of a novel Gal beta (1\u20133\/1\u20134) GlcNAc alpha 2, 3-sialyltransferase using lectin resistance selection","volume":"268","author":"Sasaki","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.03.018_bib27","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2010.03.018_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cardiores.2003.11.037","article-title":"Review of aldosterone- and angiotensin II-induced target organ damage and prevention","volume":"61","author":"Struthers","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2010.03.018_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1358\/dot.2004.40.6.850481","article-title":"Eplerenone: a new selective aldosterone receptor antagonist","volume":"40","author":"Weinberger","year":"2004","journal-title":"Drugs Today (Barc.)"},{"key":"10.1016\/j.ejphar.2010.03.018_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1254\/jphs.DTJ05001X","article-title":"Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker","volume":"100","author":"Yao","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2010.03.018_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MNH.0b013e3282f56854","article-title":"Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation","volume":"17","author":"Young","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2010.03.018_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1291\/hypres.24.429","article-title":"Benidipine dilates both pre- and post-glomerular arteriole in the canine kidney","volume":"24","author":"Yue","year":"2001","journal-title":"Hypertens. Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910002128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910002128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:49:32Z","timestamp":1739965772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910002128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":32,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0014299910002128"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.03.018","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}